CLINICAL_TRIALS
research
· 2016-10-10
Clinical Trial Update: Congenital Sucrase-Isomaltase Deficiency (CSID) Genetic Prevalence Study (GPS)
Summary
Completed genetic prevalence study on congenital sucrase-isomaltase deficiency (CSID) with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: QOL Medical, LLC | Conditions: Congenital Sucrase-isomaltase Deficiency (CSID) | Status: COMPLETED | Results posted: 2016-10-10